Factor X/Xa elicits protective signaling responses in endothelial cells directly via PAR-2 and indirectly via endothelial protein C receptor-dependent recruitment of PAR-1.
We recently demonstrated that the Gla domain-dependent interaction of protein C with endothelial protein C receptor (EPCR) leads to dissociation of the receptor from caveolin-1 and recruitment of PAR-1 to a protective signaling pathway. Thus, the activation of PAR-1 by either thrombin or PAR-1 agonist peptide elicited a barrier-protective response if endothelial cells were preincubated with protein C. In this study, we examined whether other vitamin K-dependent coagulation protease zymogens can modulate PAR-dependent signaling responses in endothelial cells. We discovered that the activation of both PAR-1 and PAR-2 in endothelial cells pretreated with factor FX (FX)-S195A, but not other procoagulant protease zymogens, also results in initiation of protective intracellular responses. Interestingly, similar to protein C, FX interaction with endothelial cells leads to dissociation of EPCR from caveolin-1 and recruitment of PAR-1 to a protective pathway. Further studies revealed that, FX activated by factor VIIa on tissue factor bearing endothelial cells also initiates protective signaling responses through the activation of PAR-2 independent of EPCR mobilization. All results could be recapitulated by the receptor agonist peptides to both PAR-1 and PAR-2. These results suggest that a cross-talk between EPCR and an unknown FX/FXa receptor, which does not require interaction with the Gla domain of FX, recruits PAR-1 to protective signaling pathways in endothelial cells.
Bae
Jong-Sup
JS
Edward A Doisy Department of Biochemistry and Molecular Biology, St. Louis University School of Medicine, St Louis, Missouri 63104, USA.
Yang
Likui
L
Rezaie
Alireza R
AR
D019943:Amino Acid Substitution; D015703:Antigens, CD / Q000235:genetics / Q000378:metabolism; D051242:Caveolin 1 / Q000235:genetics / Q000378:metabolism; D002460:Cell Line; D042783:Endothelial Cells / Q000166:cytology / Q000378:metabolism*; D000074283:Endothelial Protein C Receptor; D004789:Enzyme Activation / Q000187:drug effects / Q000502:physiology; D004792:Enzyme Precursors / Q000235:genetics / Q000378:metabolism* / Q000494:pharmacology; D015942:Factor VIIa / Q000235:genetics / Q000378:metabolism; D015951:Factor Xa / Q000235:genetics / Q000378:metabolism* / Q000494:pharmacology; D006801:Humans; D020125:Mutation, Missense; D011486:Protein C / Q000235:genetics / Q000378:metabolism / Q000494:pharmacology; D017434:Protein Structure, Tertiary; D044463:Receptor, PAR-1 / Q000235:genetics / Q000378:metabolism*; D044464:Receptor, PAR-2 / Q000235:genetics / Q000378:metabolism*; D011956:Receptors, Cell Surface / Q000819:agonists / Q000235:genetics / Q000378:metabolism; D015398:Signal Transduction / Q000187:drug effects / Q000502:physiology*
D015703:Antigens, CD; C495540:CAV1 protein, human; D051242:Caveolin 1; D000074283:Endothelial Protein C Receptor; D004792:Enzyme Precursors; C478370:PROCR protein, human; D011486:Protein C; D044463:Receptor, PAR-1; D044464:Receptor, PAR-2; D011956:Receptors, Cell Surface; D015942:Factor VIIa; D015951:Factor Xa
J Biol Chem. 2001 Mar 9;276(10):7614-20
11108718
J Immunol. 1998 Oct 15;161(8):4318-24
9780208
J Biol Chem. 1994 Feb 4;269(5):3139-42
8106347
J Biol Chem. 1995 Mar 10;270(10):5571-7
7890676
Biochemistry. 1995 Oct 31;34(43):13988-93
7577996
Blood. 2007 Apr 15;109(8):3161-72
17110453
Thromb Haemost. 1993 Jul 1;70(1):29-35
8236111
J Thromb Haemost. 2005 Dec;3(12):2798-805
16359518
EMBO J. 1989 Nov;8(11):3467-75
2583108
Circ Res. 2004 Feb 6;94(2):159-66
14656933
J Biol Chem. 2007 Mar 23;282(12):9251-9
17255099
Blood. 2007 Dec 1;110(12):3909-16
17823308
Annu Rev Biochem. 1980;49:765-811
6996572
Thromb Haemost. 1991 Jul 12;66(1):49-61
1833851
J Biol Chem. 1997 Oct 17;272(42):26279-84
9334197
Am J Pathol. 2008 Feb;172(2):309-20
18202198
J Thromb Haemost. 2010 May;8(5):1107-15
20180904
J Biol Chem. 1993 Apr 15;268(11):8176-80
8463328
J Biol Chem. 2005 Apr 29;280(17):17286-93
15710622
J Thromb Haemost. 2003 Jul;1(7):1495-503
12871285
Int J Biochem Cell Biol. 2008;40(6-7):1228-37
18420447
J Thromb Haemost. 2005 Aug;3(8):1800-14
16102047
Trends Biochem Sci. 1992 Oct;17(10):383-7
1455506
Thromb Haemost. 2008 Jul;100(1):101-9
18612544
J Biol Chem. 2005 Apr 1;280(13):13122-8
15665002
Science. 2002 Jun 7;296(5574):1880-2
12052963
Proc Natl Acad Sci U S A. 1996 Sep 17;93(19):10212-6
8816778
J Biol Chem. 1996 Jul 12;271(28):16466-71
8663335
Thromb Haemost. 2009 Mar;101(3):513-20
19277413
J Biol Chem. 2005 Sep 23;280(38):32722-8
16079143
Proc Natl Acad Sci U S A. 2007 Feb 20;104(8):2867-72
17299037
J Biol Chem. 1992 Dec 25;267(36):26104-9
1334492
J Biol Chem. 1997 Mar 28;272(13):8340-5
9079657
Proc Natl Acad Sci U S A. 2001 Jul 3;98(14):7742-7
11438726
Annu Rev Biochem. 1988;57:915-56
3052293
Blood. 2000 Jul 1;96(1):145-8
10891443
Biochemistry. 1991 Oct 29;30(43):10363-70
1931959
Blood. 2000 Mar 1;95(5):1680-6
10688824
FASEB J. 1992 May;6(8):2561-7
1317308